Obesity paradox and chronic kidney disease

Bratislava Medical Journal

Volumn 112, Issue 7, 2011, Pages 402-406

  Valocikova, I ^a   Valocik, G ^a   Kristofova, B ^a   Druzbacka, L ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

BMI; Kidney and heart function; Reverse epidemiology

Indexed keywords

CREATININE;

AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY;

AGED; BODY MASS INDEX; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; OBESITY; RENAL INSUFFICIENCY, CHRONIC; STROKE VOLUME;

EID: 79960539681     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Curtis JP, Selter JG, Yongfei W et al. The obesity paradox. Body Mass Index and Outcomes in Patients With Heart Failure. Arch Intern Med2005; 165: 55-61.
2. Mehta LS, Skedling KA, Grines LL et al. Obesity: protective in acute myocardial infarction patients ? (abstract). Circulation 2002; 106 (Suppl 2): 402.
3. Ness AR, Gunnell D, Hughes J et al. Height, body mass index, and survival in men with coronary disease. Follow up of the Diet and Rein-farction Trial (DART). J Epidemiol Comm Health 2002; 56: 218-219.
4. Lavie CJ, Mandeep RM, Milani RV. Obesity and heart failure prog nosis: paradox or reverse epidemiology? Eur Heart J 2005; 26: 5-7.
5. Kalantar-Zadeh K. What Is So Bad about Reverse Epidemiology Anyway? Semin Dialysis 2007; 20: 593-601.
6. Horwich TB, Fonarow GC, Hamilton MA et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38: 789-795.
7. Davos CH, Doehner W, Rauchhaus M et al. Body mass and survi val in patients with chronic heart failure without cachexia: the importan ce of obesity. J Card Fail 2003; 9: 9-25.
8. Mostard A, Cost B, Hoes AW et al. The prognosis of heart failure in the general population. Eur Heart J 2001; 22: 1318-1327.
9. Mafra D, Guebre-Egziabher F, Fouque D. Body mass index, musc le and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant 2008; 23: 2461-2466. 406
10. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical asso ciation between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 2007; 49: 581-591.
11. Johanssen KL, Young B, Kaysen GA et al. Association of body size with outcomes among patients begining dialysis. Am J Clin Nutr 2004; 80: 324-332.
12. Devereux BR, Alonso DR, Lutas EM, Gottleib GD, Campo E, Sach I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy. Am J Cardiol 1986; 57: 450-458.
13. Kalantar-Zadeh K, Kopple JD. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 2006; 151: 57-69.
14. Kalantar-Zadeh K, Kuwae N, Wu Dy et al. Associations of body fat and its changes over time with quality of life and prospective morta lity in haemodialysis patients. Am J Clin Nutr 2006; 83: 202-210.
15. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543-554.
16. Leavey SF, Strawderman RL, Jones CA et al. Body mass index and mortality in "healthier" as compared with "sicker" haemodialysis patients. Results from the Dialysis Outcomes and Practice Patterns Stu dy (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394.
17. Poludasu S, Cavusogiu E, Wagas K et al. Impact of Body Mass Index on Long-Term All Mortality after Percutaneous Coronary Inter vention in African-Americans. J Invasive Cardiol 2009; 21: 20-25.
18. Oreopoulos A, Padwal R, Norris CM et al. Effect of obesity on short- and long-term mortality postcoronary revascularization: a metaanalysis. Obesity 2008; 16: 442-450.
19. Oreopoulos A, Padwal R, Kalantar-Zadeh K et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008; 156: 13-22.
20. Wu IW, Hung MJ, Chen YCH et al. High Body Mass Index is not Associated With Coronary Artery Disease in Angina Patients With Chro nic Kidney Disease: A Coronary Angiography Study. Am J Med Sci 2008; 336: 303-308.
21. Ejerblad E, Fored MC, Lindblad P et al. Obesity and Risk for Chronic Renal Failure. J Am Soc Nephrol 2006; 17: 1695-1702.
22. Caravaca F, Martin MV, Barrosi S et al. Obesity and mortality in advanced chronic renal failure patients. Nefrologia 2004; 24: 453-462 (abstract).
23. Chi-Yuan H, McCulloch E, Irbarren C et al. Body mass Index and Risk for End-Stage Renal Disease. Ann Intern Med 2006; 144: 21-28.
24. Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact or fiction? Am J Cardiol 2006; 98: 944-948.
25. Feldman AM, Combes A, Wagner D et al. The role of tumor ne crosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000; 35: 537-544.
26. Mohamed-Ali V, Goodrick S, Bulmer K et al. Production of so luble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999; 277: E971-975.
27. Weber MA, Neutel JM, Smith DH. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol 2001; 37: 169-174.